Scott Merz, Business Development Manager at Asahi Kasei Bioprocess America, provides his take on the recent oligonucleotide manufacturing market growth, key considerations for development, and common challenges that arise when scaling up equipment.
Not yet a member of Pharmaceutical Online? Register today.
Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.
You might also want to: